glp 1 agonist in ckd Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Kidney Outcomes With Glucagon-Like Peptide-1
Description
Sci Rep (2020) 10(1):16758
Several mechanisms may be involved in this potential association, some of which include sudden weight loss and hyperactivity of the hypothalamic-pituitary-adrenal axis
D.AmarJ.IglesiasM
Strey, G
however, emerging evidence suggests that the effects extend beyond metabolic regulation
GLP-1 appears to attenuate the process of neuroinflammation and protects neurons and glia under oxidative stress conditions in the depressive brain
